TRANSGLUTAMINASE ACTIVITY IS INCREASED IN ALZHEIMERS-DISEASE BRAIN

Citation
Gvw. Johnson et al., TRANSGLUTAMINASE ACTIVITY IS INCREASED IN ALZHEIMERS-DISEASE BRAIN, Brain research, 751(2), 1997, pp. 323-329
Citations number
55
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
00068993
Volume
751
Issue
2
Year of publication
1997
Pages
323 - 329
Database
ISI
SICI code
0006-8993(1997)751:2<323:TAIIIA>2.0.ZU;2-5
Abstract
Transglutaminase is a calcium-activated enzyme that crosslinks substra te proteins into insoluble, often filamentous aggregates resistant to proteases. Because the neurofibrillary tangles in Alzheimer's disease have similar characteristics, and because tau protein, the major compo nent of these tangles is an excellent substrate of transglutaminase in vitro, transglutaminase activity and levels were measured in control and Alzheimer's disease brain. Frozen prefrontal cortex and cerebellum samples from Alzheimer's disease and control cases matched for age an d postmortem interval were used in the analyses. Total transglutaminas e activity was significantly higher in the Alzheimer's disease prefron tal cortex compared to control. In addition the levels of tissue trans glutaminase, as determined by quantitative immunoblotting, were elevat ed approximately 3-fold in Alzheimer's disease prefrontal cortex compa red to control. To our knowledge, this is the first demonstration that transglutaminase is increased in Alzheimer's disease brain. There wer e no significant differences in transglutaminase activity or levels in the cerebellum between control and Alzheimer's disease cases. Because the elevation of transglutaminase in the Alzheimer's disease samples occurred in the prefrontal cortex, where neurofibrillary pathology is usually abundant, and not in the cerebellum, which is usually spared i n Alzheimer's disease, it can be suggested that transglutaminase could be a contributing factor in neurofibrillary tangle formation.